Lecturer | Presentations | Duration |
James L. Cox
(La Grange, CO, USA) | The interventional treatment of atrial fibrillation (In vivo remodeling potential of a novel bioprostheric tricuspid valve in an ovine model) | 36:13 |
Closure of the la appendage - should we be more aggressive? (Mechanical closure of the left atrial appendage: Is it time to be more aggressive?) | 58:44 |
Leo A. Bockeria
(Moscow, Russia) | A La Cox-MAZE-III procedure
| 28:25 |
Paul Sergeant
(Leuven, Belgium) | Can we eliminate the stroke in CABG?
| 22:39 |
Conversion in OPCAB, can it be avoided? | 22:39 |
Lars G. Svensson
(Cleveland, OH, USA) | Aortic valve repair and root procedures | 25:24 |
Hybrid procedures of the arch and distal aorta including elephant trunk procedures (Current indications, techniques and outcomes of thoracic aortic arch surgery and hybrid stenting) | 23:44 |
Ottavio R. Alfieri
(Milano, Italy) | The evolution from surgery to percutaneous mitral valve interventions | 30:18 |
Current strategies in the management of secondary (functional) mitral regurgitation | 28:18 |
Tricuspid regurgitation in different clinical scenarios: Surgical options and percutaneous perspectives | 27:58 |
Sergey Leontyev
(Leipzig, Germany) | Transcatheter and transapical aortic valve replacement | 36:22 |
Syntax study: Final results and implications | 30:33 |
Pedro J. Del Nido
(Boston, MA, USA) | Valve reconstruction for congenital mitral valve disease | 23:24 |
Tricuspid valve repair: From Ebstein's to functional tricuspid regurgitation | 25:22 |
Ludwig von Segesser
(Lausanne, Switzerland) | Growing indications for catheter valves | 26:34 |
Echo-guided cardiovascular surgery | 17:31 |
Marko Turina
(Zurich, Switzerland ) | How useful are guidelines in coronary revascularization? (Guidelines in coronary revascularization: A critical reassessment) | 32:40 |
Lorenzo A. Menicanti
(Milano, Italy) | The retionale to use saphenous vein graft in CABG in era of total arterial revascularization (Long-term results of sequential vein aortocoronary bypass grafting compared to totally arterial myocardial revascularization. A propensity score-matched follow-up study) | 25:27 |
Ischemic mitral regurgitation is ventricular matter, surgical implications | 29:39 |
Ventricular remodelling operation is there a need? (Left ventricular reconstruction concomitant to coronary artery bypass grafting: When and how?) | 29:39 |
Robert A.E. Doin
(Genk, Belgium) | Functional TR: When and how to intervene? | 33:03 |
Transatrial surgical approach to HOCM (Myectomy and mitral repair through the left atrium in hypertrophic obstructive cardiomyopathy: The preferred approach for contemporary surgical candidates?) | 29:39 |
David Taggart
(Oxford, UK) | CABG and stents in 2014 (BIMA for CABG) | 41:26 |
Arterial grafts for CABG in 2014 (CABG after recent trials) | 30:15 |
Roberto Chiesa
(Milano, Italy) | Thoracic aortic infections: Single centre experience and national registry investigation | 25:15 |
Acute aortic syndrome: Open and endovascular management | 29:20 |
Thierry P. Carrel
(Berne, Switzerland) | Malperfusion in acute aortic dissection: Early detection and treatment (Malperfusion in acute aortic dissection type A) | 30:28 |
Mini-ECC perfusion for CABG surgery (Minimize cardiopulmonary bypass combined with a smart suction device is future of cardiopulmonary bypass) | 29:20 |